arrow
K

Keiichi Ohshima

shizuoka cancer center research institute
H指数:31
被引数:4,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Des-Gamma-Carboxy Prothrombin Is Associated With Tumor Aggressiveness and Recurrence in Resected Early-Stage Hepatocellular Carcinoma: A Clinicopathological and Molecular Analysis

γ-羧基缺失凝血酶原与切除术后早期肝癌的肿瘤侵袭性和复发相关:一项临床病理和分子分析

2026-09-080
PRE
Characterization of the immune status in the tumor microenvironment of solid cancers with chromosomal instability

染色体不稳定型实体癌症肿瘤微环境中免疫状态的表征

2026-09-060
OA
Profiling the tumor immunological status in Japanese solid cancers using the tumor immune status scoring algorithm

利用肿瘤免疫状态评分算法分析日本实体瘤的肿瘤免疫状态

2026-04-250
OAAI
Translating spatial transcriptomic signatures in adenosquamous carcinoma into bulk prognostic biomarkers in lung adenocarcinoma: a bottom-up approach

将腺鳞癌的空间转录组特征转化为肺腺癌的大量预后生物标志物: 自下而上的方法

2026-01-230
OAAI
Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing

由全基因组长读测序揭示的新型CYP2A7/CYP2A6种系嵌合体与肺癌突变负荷的关联

2025-11-210
OAAI
Pancancer Landscape of Long Non-coding RNA Expression and Immune Status of the Tumor Microenvironment in Japanese Cancer Patients

泛癌种背景下日本癌症患者中长链非编码RNA表达及肿瘤微环境免疫状态的景观

2025-10-010
OAAI
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer

基于肿瘤表型的分类能够实现食管胃结合部癌的新型分子特征描述

2025-09-260
PRE
Characterization of the Neoantigen Profile in a Tumor Mutation Burden-high Melanoma Patient With Multiple Metastases

高肿瘤突变负荷伴多发转移的黑色素瘤患者新抗原特征的表征

2025-04-250
OA
Localization of epidermal growth factor receptor-mutations using PNA:DNA probes in clinical specimens from patients with non-small cell lung cancer

在非小细胞肺癌患者的临床标本中使用PNA:DNA探针定位表皮生长因子受体突变

2025-04-020
OAAI
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome

评估全基因组测序在识别癌症基因组驱动改变中的效用

2024-10-120
OAAI
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes
2022-10-261
OAAI